ESCMID eLibrary

Search results
Icon explanation








-
P1291
Comparative in vitro activity of ceftazidime-avibactam against Gram-negative pathogens from hospital-acquired lower respiratory tract infections in the European union: 2013 INFORM surveillance programme
28 April 2015
Session: New data on new cephalosporin/beta-lactamase inhibitor combinations
-
P1292
Antimicrobial resistance patterns of ceftazidime-avibactam and comparators against intra-abdominal Gram-negative pathogens from Europe: international network for optimal resistance monitoring (INFORM) global surveillance study 2013
28 April 2015
Session: New data on new cephalosporin/beta-lactamase inhibitor combinations
-
P1293
Activity of ceftazidime-avibactam and comparators against carbapenemase-producing Enterobacteriaceae isolated in sampled countries of the European Union: 2013 INFORM surveillance programme
28 April 2015
Session: New data on new cephalosporin/beta-lactamase inhibitor combinations
-
P1294
In vitro activity of ceftazidime-avibactam and other agents against Pseudomonas aeruginosa isolated in selected countries of the European union in 2013
28 April 2015
Session: New data on new cephalosporin/beta-lactamase inhibitor combinations
-
P1053
Current status of carbapenem-resistant Enterobacteriaceae (CRE) in Europe
27 April 2015
Session: Recent epidemiological data on carbapenem-resistant Enterobacteriaceae
-
P0967
Antimicrobial susceptibility profiles of key intra-abdominal (IAI) bacterial isolates from western Europe
27 April 2015
Session: More and more third generation cephalosporin-resistent enteric bacteria everywhere?
-
P0961
Molecular profiling of beta-lactam-resistant Enterobacteriaceae collected as part of the Tigecycline European Surveillance Trial (TEST) in 2012-2013
27 April 2015
Session: More and more third generation cephalosporin-resistent enteric bacteria everywhere?
-
P1778
Tigecycline activity against enteric pathogens resistant to amikacin as determined from TEST program analysis over ten years - TEST 2013
13 May 2014
Session: MDR Gram-negatives - clinical observations
-
P1781
Activity of ceftazidime-avibactam and comparators versus characterised ESBL-positive Gram-negative bacteria isolated in the European region: 2012 programme
13 May 2014
Session: MDR Gram-negatives - clinical observations
-
P1782
Activity of ceftazidime-avibactam versus Pseudomonas aeruginosa, including multiple-drug resistant isolates in Europe - the 2012 INFORM programme
13 May 2014
Session: MDR Gram-negatives - clinical observations
Search narrowed by
-
Topics
-
Type of material
-
Time period